Tianxin Lin
5PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 09, 2025
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4-Targeted Antibody-Drug Conjugate Enfortumab Vedotin in Bladder Cancer.Jilin Wu, Bisheng Cheng, Yuxuan Song
|Jul 15, 2025
Intravesical Disitamab Vedotin (RC48) for HER2-Expressing High-Risk Non-Muscle-Invasive Bladder Cancer: A Single-Arm, Dose-Escalation Phase I Trial Study.Xu Chen, Ming Huang, Zehua Chen
|Feb 19, 2025
Contrast-enhanced ultrasound enables precision diagnosis of preoperative muscle invasion in bladder cancer: a prospective study.Qiyun Ou, Weibin Xie, Yunfang Yu
|Aug 19, 2024
Oncogenic SLC2A11-MIF fusion protein interacts with polypyrimidine tract binding protein 1 to facilitate bladder cancer proliferation and metastasis by regulating mRNA stability.Liang Cheng, Chenwei Yang, Junlin Lu
|Mar 20, 2023
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.Ruihui Xie, Liang Cheng, Ming Huang
Pageof 1
